- Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
Yuee Cai et al, 2016, Molecular Pharmaceutics CrossRef - Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-κB Signaling Pathway
Gabriel Alves Bonafé et al, 2019, Frontiers in Cellular Neuroscience CrossRef - Ethnopharmacological Survey of Medicinal Plants Used by Local Herbalists and Traditional Healers for the Treatment of Cancer in Jordan
Yahia Tabaza et al, 2024, Current Traditional Medicine CrossRef - Core–Shell Nanostructured Drug Delivery Platform Based on Biocompatible Metal–Organic Framework-Ligated Polyethyleneimine for Targeted Hepatocellular Carcinoma Therapy
Mostafa Fytory et al, 2023, ACS Omega CrossRef - Glycyrrhizin for treatment of CRS caused by CAR T-cell therapy: A pharmacological perspective
Xingxing Qi et al, 2023, Frontiers in Pharmacology CrossRef - Brucine Sensitizes HepG2 Human Liver Cancer Cells to 5-fluorouracil via Fas/FasL Apoptotic Pathway
Guoquan Fan et al, 2017, International Journal of Pharmacology CrossRef - Natural Plant Compounds: Does Caffeine, Dipotassium Glycyrrhizinate, Curcumin, and Euphol Play Roles as Antitumoral Compounds in Glioblastoma Cell Lines?
Gabriel Alves Bonafé et al, 2022, Frontiers in Neurology CrossRef